The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Amicus Therapeutics Inc. Common 03152W109   4,306,158 388,292 SH   SOLE   388,292 0 0
Arcutis Biotherapeutics inc Common 03969K108   2,795,507 254,137 SH   SOLE   254,137 0 0
AVROBIO, Inc. Common 05455M100   647,918 647,918 SH   SOLE   647,918 0 0
Axsome Therapeutics, Inc. Common 05464T104   4,342,395 70,402 SH   SOLE   70,402 0 0
Black Diamond Therapeutics, Inc. Common 09203E105   273,838 144,888 SH   SOLE   144,888 0 0
Chinook Therapeutics, Inc. Common 16961L106   4,579,209 197,806 SH   SOLE   197,806 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107   5,787,896 360,392 SH   SOLE   360,392 0 0
Cullinan Oncology, Inc. Common 230031106   78,241,782 7,648,268 SH   SOLE   7,648,268 0 0
Geron Corporation Common 374163103   18,231,396 8,401,565 SH   SOLE   8,401,565 0 0
Harpoon Therapeutics, Inc. Common 41358P106   2,378,350 3,196,707 SH   SOLE   3,196,707 0 0
Inhibrx, Inc Com Common 45720L107   22,498,342 1,192,281 SH   SOLE   1,192,281 0 0
Inozyme Pharma Inc. Common 45790W108   1,339,261 233,728 SH   SOLE   233,728 0 0
Insmed Incorporated Common 457669307   6,806,224 399,192 SH   SOLE   399,192 0 0
Intellia Therapeutics, Inc. Common 45826J105   21,335,547 572,459 SH   SOLE   572,459 0 0
Iovance Biotherapeutics Inc Com Common 462260100   15,977,509 2,614,977 SH   SOLE   2,614,977 0 0
iTeos Therapeutics, Inc. Common 46565G104   23,762,284 1,745,943 SH   SOLE   1,745,943 0 0
Iveric Bio Inc Common 46583P102   25,441,662 1,045,691 SH   SOLE   1,045,691 0 0
Madrigal Pharmaceuticals inc Common 558868105   8,730,566 36,038 SH   SOLE   36,038 0 0
Oncorus, Inc. Common 68236R103   817,699 2,377,031 SH   SOLE   2,377,031 0 0
Phathom Pharmaceuticals inc Common 71722W107   1,518,071 212,615 SH   SOLE   212,615 0 0
Provention Bio Inc Common 74374N102   28,288,797 1,173,809 SH   SOLE   1,173,809 0 0
Reata Pharmaceuticals inc-a Common 75615P103   16,544,794 176,874 SH   SOLE   176,874 0 0
REGENXBIO Inc. Common 75901B107   11,680,159 617,671 SH   SOLE   617,671 0 0
Relay Therapeutics Inc. Common 75943R102   20,186,192 1,225,634 SH   SOLE   1,225,634 0 0
Repare Therapeutics, Inc. Common 760273102   16,136,114 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100   5,350,497 247,022 SH   SOLE   247,022 0 0
TCR2 Therapeutics, Inc. Common 87808K106   5,056,473 3,370,982 SH   SOLE   3,370,982 0 0
Travere Therapeutics Inc. Common 89422G107   7,053,809 313,642 SH   SOLE   313,642 0 0
Uniqure N.V. Common N90064101   7,013,231 348,224 SH   SOLE   348,224 0 0
Verve Therapeutics, Inc Common 92539P101   11,586,484 803,501 SH   SOLE   803,501 0 0
Werewolf Therapeutics, Inc. Common 95075A107   6,208,829 2,388,011 SH   SOLE   2,388,011 0 0